Debt (Details) $ / shares in Units, $ in Thousands |
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
|
|
|
Jul. 19, 2021
USD ($)
$ / shares
|
Nov. 09, 2020
USD ($)
shares
|
Oct. 31, 2020
USD ($)
$ / shares
|
Jul. 31, 2020
USD ($)
$ / shares
|
Apr. 30, 2019
USD ($)
$ / shares
shares
|
Feb. 28, 2022
EUR (€)
|
Nov. 30, 2020
USD ($)
|
Jul. 31, 2020
USD ($)
$ / shares
|
Apr. 30, 2019
USD ($)
$ / shares
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2021
COP ($)
shares
|
Jan. 31, 2021
USD ($)
|
Jan. 31, 2021
EUR (€)
|
Aug. 31, 2020
USD ($)
$ / shares
shares
|
Mar. 31, 2020 |
Mar. 31, 2019
USD ($)
$ / shares
shares
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt issuance amortization |
|
|
|
|
|
|
|
|
|
$ 4,227,000
|
$ 426,000
|
[1] |
|
|
|
|
|
|
Maturity date |
|
|
|
Jun. 30, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on debt extinguishment |
|
|
|
|
|
|
|
|
|
(3,262,000)
|
2,360,000
|
|
|
|
|
|
|
|
Loss on fair value of derivative instrument |
|
|
|
|
|
|
|
|
|
|
(657,000)
|
|
|
|
|
|
|
|
Loans and borrowings |
|
|
|
|
|
|
|
|
|
$ 25,095,000
|
33,843,000
|
|
|
|
|
|
|
|
Strike price per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 11.5
|
|
|
|
|
|
|
|
|
Additional paid in capital |
|
|
|
|
|
|
|
|
|
$ 4,748,000
|
|
|
|
|
|
|
|
|
Common shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
7,000
|
|
|
|
|
|
|
|
|
Conversion value |
|
|
|
|
|
|
|
|
|
$ 6,047,000
|
|
|
|
|
|
|
|
|
Accrued interest |
|
|
|
|
|
|
|
|
|
26,538,000
|
4,191,000
|
|
|
|
|
|
|
|
Convertible Notes [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt issuance costs and debt discount |
|
|
|
|
|
|
|
|
|
2,197,000
|
|
|
|
|
|
|
|
|
Debt issuance costs, net |
|
|
|
|
|
|
|
|
|
|
741,000
|
|
|
|
|
|
|
|
Write off of unamortized debt financing cost |
|
|
|
|
|
|
|
|
|
$ 483,000
|
|
|
|
|
|
|
|
|
Series D Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of securities called by warrants or rights (in Shares) | shares |
|
|
|
|
|
|
|
|
|
9,509
|
|
|
9,509
|
|
|
|
|
|
Herbal Brands Loan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt, current portion |
|
|
|
|
|
|
|
|
|
$ 880,000
|
|
|
|
|
|
|
|
|
Debt issuance amortization |
|
|
|
|
|
|
|
|
|
410,000
|
|
|
|
|
|
|
|
|
Neem Holdings Convertible Note [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, face amount |
|
$ 3,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of securities called by warrants or rights (in Shares) | shares |
|
300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Neem Holdings Convertible Note [Member] | Neem Holdings [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, face amount |
|
$ 3,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
fair value of the debt instrument |
|
$ 3,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Neem Holdings Convertible Note [Member] | Series D Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt termination of business combination, issuance of preferred shares (in Shares) | shares |
|
194,805
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series E Convertible Debentures [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt issuance costs, net |
|
|
|
$ 181,000
|
|
|
|
$ 181,000
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, face amount |
|
|
|
$ 4,162,000
|
|
|
|
$ 4,162,000
|
|
$ 4,162,000
|
|
|
|
|
|
|
|
|
Interest per annum |
|
|
|
8.00%
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
Price per share (in Dollars per share) | $ / shares |
|
|
|
$ 5.95
|
|
|
|
$ 5.95
|
|
|
|
|
|
|
|
|
|
|
Common share percentage |
|
|
|
70.00%
|
|
|
|
70.00%
|
|
|
|
|
|
|
|
|
|
|
Future conversion price, discount, redemption feature |
|
|
|
30.00%
|
|
|
|
30.00%
|
|
|
|
|
|
|
|
|
|
|
Fair value of the derivative |
|
|
|
$ 1,705,000
|
|
|
|
$ 1,705,000
|
|
|
|
|
|
|
|
|
|
|
Derivative liability, redemption feature probability percentage |
|
|
|
90.00%
|
|
|
|
90.00%
|
|
|
|
|
|
|
|
|
|
|
Embedded derivative, carrying value |
|
|
|
$ 2,457,000
|
|
|
|
$ 2,457,000
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on debt extinguishment |
|
|
|
|
|
|
|
1,705,000
|
|
|
|
|
|
|
|
|
|
|
Loss on fair value of derivative instrument |
|
|
|
|
|
|
|
85,000
|
|
|
|
|
|
|
|
|
|
|
Series E Convertible Debentures [Member] | Class A Common Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate purchase price |
|
|
|
|
|
|
|
$ 5,950,000
|
|
|
|
|
|
|
|
|
|
|
Conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 2.303
|
|
|
|
|
|
|
|
|
Series D Convertible Notes due March 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on debt extinguishment |
|
|
|
|
|
|
|
|
|
$ 2,267,000
|
|
|
|
|
|
|
|
|
Weighted average price exceeding per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13.54
|
Per share percentage |
|
|
|
|
|
|
|
|
|
95.00%
|
|
|
95.00%
|
|
|
|
|
|
Pro rata percentage |
|
|
|
|
|
|
|
|
|
25.00%
|
|
|
25.00%
|
|
|
|
|
|
Pro rata percentage of net proceeds |
|
|
|
|
|
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
Aggregate net proceeds |
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate outstanding percentage |
90.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2024 Note Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt issuance costs and debt discount |
$ 965,000
|
|
|
|
|
|
|
|
|
$ 17,699,000
|
|
|
|
|
|
|
|
|
Debt issuance costs, net |
630,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, face amount |
|
|
|
|
|
|
|
|
|
$ 12,500,000
|
|
|
|
|
|
|
|
|
Discount to the closing price per share percentage |
|
|
|
|
|
|
|
|
|
8.00%
|
|
|
8.00%
|
|
|
|
|
|
Optional redemption rate per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 6.44
|
|
|
|
|
|
|
|
|
Exceed amount |
$ 3,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding common shares percentage |
9.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible note discription |
|
|
|
|
|
|
|
|
|
The occurrence of these events of default would give rise to a 5% increase in the interest rate to a total of 10% per annum for as long as the event of default continues and give the holder of the Convertible Note the right to redeem the outstanding principal and accrued interest on the Convertible Note at the Optional Redemption Rate. Certain events of default also require the Company to repay all outstanding principal and accrued interest on the Convertible Note. In addition, in certain circumstances, if the Company fails to timely deliver common shares as required upon conversion or redemption of the Convertible Note, then the Company will be required to pay, on each day that such failure to deliver common shares continues, an amount in cash equal to 0.75% of the product of (x) the number of common shares the Company failed to deliver (on or prior to share delivery deadline and to which holder is entitled) multiplied by (y) any closing trading price of the common shares (selected by the Holder in writing during the period beginning on the applicable Conversion/Redemption Date and ending on the applicable Conversion/Redemption Share Delivery Deadline.) The obligations of the Company under the Note Purchase Agreement are guaranteed by certain of the Company’s subsidiaries.
|
|
|
|
|
|
|
|
|
Total debt amortization |
|
|
|
|
|
|
|
|
|
$ 3,519,000
|
|
|
|
|
|
|
|
|
Recognized earnings |
$ 9,496,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BCF amount |
|
|
|
|
|
|
|
|
|
$ 4,748,000
|
|
|
|
|
|
|
|
|
Debt discount |
335,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
720,085
|
|
|
|
|
|
|
|
|
Aggregate principal amount |
|
|
|
|
|
|
|
|
|
$ 5,559,000
|
|
|
|
|
|
|
|
|
2024 Note Purchase Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion value |
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
Accrued interest |
|
|
|
|
|
|
|
|
|
3,500,000
|
|
|
|
|
|
|
|
|
Debt Instrument, Redemption, Period Two [Member] | 2024 Note Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, face amount |
12,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exceed amount |
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Herbal Brands, Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, face amount |
|
|
|
|
$ 8,500,000
|
|
|
|
$ 8,500,000
|
|
|
|
|
|
|
|
|
|
Interest per annum |
|
|
|
|
8.00%
|
|
|
|
8.00%
|
|
|
|
|
|
|
4.00%
|
|
|
Percentage of repayment of positive operating cash flow |
|
|
|
|
85.00%
|
|
|
|
85.00%
|
|
|
|
|
|
|
|
|
|
Net interest payment |
|
|
|
|
$ 2,338,000
|
|
|
|
$ 2,338,000
|
|
|
|
|
|
|
|
|
|
Herbal Brands, Inc. [Member] | Non-Revolving Credit Facility [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt issuance costs, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 400,000
|
|
|
Recognized interest expense |
|
|
|
|
|
|
|
|
|
733,000
|
704,000
|
|
|
|
|
|
|
|
Repaid principal amount |
|
|
|
|
|
|
|
|
|
$ 1,495,000
|
$ 1,191,000
|
|
|
|
|
|
|
|
October 2020 Convertible Debenture Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, face amount |
|
|
$ 1,230,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest per annum |
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Price per share (in Dollars per share) | $ / shares |
|
|
$ 5.95
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common share percentage |
|
|
70.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of the derivative |
|
|
$ 570,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liability, redemption feature probability percentage |
|
|
43.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Embedded derivative, carrying value |
|
|
$ 2,160,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on debt extinguishment |
|
|
570,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on fair value of derivative instrument |
|
|
$ 600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 2020 Convertible Debenture Financing [Member] | Class A Common Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price (in Dollars per share) | $ / shares |
|
|
$ 2,303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
October 2020 Convertible Debenture Financing [Member] | Clever Leaves [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, face amount |
|
|
$ 2,730,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate investment |
|
|
|
|
|
|
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Notes Payable [Member] | Series D Convertible Notes due March 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, face amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 27,750,000
|
Interest per annum |
|
|
|
|
|
|
|
|
|
8.00%
|
|
|
8.00%
|
|
|
|
10.00%
|
8.00%
|
Conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11
|
Common shares (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,300,002
|
Common share principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
Weighted average price exceeding per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13.54
|
Convertible debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 27,750,000
|
Per share percentage |
|
|
|
|
|
|
|
|
|
95.00%
|
|
|
95.00%
|
|
|
|
|
|
Periodic payment, interest |
|
|
|
|
|
|
|
|
|
$ 2,000
|
|
|
|
|
|
|
|
|
Net proceeds |
|
|
|
|
|
|
|
|
|
$ 25,000,000
|
|
|
|
|
|
|
|
|
Convertible Notes Payable [Member] | Series D Convertible Notes due March 2022 [Member] | Series C Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 30,258,000
|
Convertible Notes Payable [Member] | 2024 Note Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest per annum |
5.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price (in Dollars per share) | $ / shares |
$ 13.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
$ 25,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of issuance |
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum [Member] | Series D Convertible Notes due March 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 11
|
|
|
|
|
|
|
|
|
Minimum [Member] | 2024 Note Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares per share (in Dollars per share) | $ / shares |
$ 7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum [Member] | Series D Convertible Notes due March 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.3062
|
|
|
|
|
|
|
|
|
Maximum [Member] | 2024 Note Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares per share (in Dollars per share) | $ / shares |
$ 7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum [Member] | Convertible Notes Payable [Member] | 2024 Note Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate purchase price |
|
|
|
|
|
|
|
|
|
$ 12,500,000
|
|
|
|
|
|
|
|
|
Convertible Debt Covenant, Threshold One [Member] | 2024 Note Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, face amount |
$ 12,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price (in Dollars per share) | $ / shares |
$ 7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Debt Covenant, Threshold Two [Member] | 2024 Note Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price (in Dollars per share) | $ / shares |
$ 7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Neem Holdings Warrants [Member] | Neem Holdings Convertible Note [Member] | Neem Holdings [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate purchase price |
|
$ 3,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional Paid-in Capital [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid in capital |
|
|
|
|
|
|
|
|
|
4,748,000
|
|
|
|
|
|
|
|
|
Conversion value |
|
|
|
|
|
|
|
|
|
6,047,000
|
|
|
|
|
|
|
|
|
Additional Paid-in Capital [Member] | 2024 Note Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid in capital |
|
|
|
|
|
|
|
|
|
4,748,000
|
|
|
|
|
|
|
|
|
PORTUGAL | Foreign Line of Credit [Member] | Clever Leaves Portugal Unipessoal LDA [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,213,000
|
€ 1,000,000
|
|
|
|
PORTUGAL | Foreign Line of Credit [Member] | Forecast [Member] | Clever Leaves Portugal Unipessoal LDA [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Installments (in Euro) | € |
|
|
|
|
|
€ 63,000
|
|
|
|
|
|
|
|
|
|
|
|
|
COLOMBIA | Secured Debt [Member] | Ecomedics S.A.S. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt instrument, face amount |
|
|
|
|
|
|
|
|
|
1,222,000
|
|
|
$ 5,015,800
|
|
|
|
|
|
Loans and borrowings |
|
|
|
|
|
|
|
|
|
$ 1,153,000
|
|
|
$ 4,592,095
|
|
|
|
|
|
COLOMBIA | Minimum [Member] | Secured Debt [Member] | Ecomedics S.A.S. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest per annum |
|
|
|
|
|
|
|
|
|
12.20%
|
|
|
12.20%
|
|
|
|
|
|
COLOMBIA | Maximum [Member] | Secured Debt [Member] | Ecomedics S.A.S. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest per annum |
|
|
|
|
|
|
|
|
|
12.25%
|
|
|
12.25%
|
|
|
|
|
|
Rock Cliff [Member] | Herbal Brands, Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of securities called by warrants or rights (in Shares) | shares |
|
|
|
|
|
|
|
|
|
63,597
|
|
|
63,597
|
|
|
63,597
|
|
|
Strike price per share (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 26.73
|
|
|
|
|
|
$ 26.73
|
|
|
Rock Cliff [Member] | Herbal Brands, Inc. [Member] | Series C Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of securities called by warrants or rights (in Shares) | shares |
|
|
|
|
193,402
|
|
|
|
193,402
|
193,402
|
|
|
193,402
|
|
|
|
|
|
Initial fair value |
|
|
|
|
|
|
|
|
$ 717,000
|
$ 717,000
|
|
|
|
|
|
|
|
|
Strike price per share (in Dollars per share) | $ / shares |
|
|
|
|
$ 8.79
|
|
|
|
$ 8.79
|
$ 8.79
|
|
|
|
|
|
|
|
|
Rock Cliff [Member] | Warrant [Member] | Herbal Brands, Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and borrowings |
|
|
|
|
$ 7,783,000
|
|
|
|
$ 7,783,000
|
|
|
|
|
|
|
|
|
|
Initial fair value |
|
|
|
|
717,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital |
|
|
|
|
$ 717,000
|
|
|
|
$ 717,000
|
|
|
|
|
|
|
|
|
|
Rock Cliff [Member] | Warrant [Member] | Herbal Brands, Inc. [Member] | Series C Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt amortization |
|
|
|
|
|
|
|
|
|
$ 410,000
|
|
|
|
|
|
|
|
|
|
|